Anxo Pharmaceutical Co Ltd logo

Anxo Pharmaceutical Co Ltd

ROCO:6677 (Taiwan)  
NT$ 50.70 (-1.74%) Sep 22
P/E:
78.04
P/B:
3.53
Market Cap:
NT$ 2.53B ($ 78.74M)
Enterprise V:
NT$ 3.19B ($ 99.22M)
Volume:
74.65K
Avg Vol (2M):
197.41K
Volume:
74.65K
Market Cap NT$:
2.53B
Market Cap $:
78.74M
PE Ratio:
78.04
Avg Vol (2M):
197.41K
Enterprise Value NT$:
3.19B
Enterprise Value $:
99.22M
PB Ratio:
3.53

Business Description

Description
Anxo Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in developing drugs which include prescription medication and consumer healthcare medication. The products of the company include cardiovascular system medication, central nervous system medication, diabetes medication, infectious medicine, and dermatology medication.
Name Current Vs Industry Vs History
Cash-To-Debt 0.25
Equity-to-Asset 0.38
Debt-to-Equity 1.2
Debt-to-EBITDA 5.96
Interest Coverage 3.83
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.95
Distress
Grey
Safe
Beneish M-Score -2.45
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 17.95
9-Day RSI 29.17
14-Day RSI 36.81
6-1 Month Momentum % 1.04
12-1 Month Momentum % 163.66

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.36
Quick Ratio 0.87
Cash Ratio 0.41
Days Inventory 163.99
Days Sales Outstanding 75.6
Days Payable 58.22

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.4
Shareholder Yield % -0.06

Financials

ROCO:6677's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Anxo Pharmaceutical Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil NT$) 941.249
EPS (TTM) (NT$) 0.665
Beta 0.43
Volatility % 95.48
14-Day RSI 36.81
14-Day ATR (NT$) 2.280512
20-Day SMA (NT$) 54
12-1 Month Momentum % 163.66
52-Week Range (NT$) 17.939025 - 74.456599
Shares Outstanding (Mil) 49.94

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Anxo Pharmaceutical Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Anxo Pharmaceutical Co Ltd Stock Events

Event Date Price(NT$)
No Event Data

Anxo Pharmaceutical Co Ltd Frequently Asked Questions

What is Anxo Pharmaceutical Co Ltd(ROCO:6677)'s stock price today?
The current price of ROCO:6677 is NT$50.70. The 52 week high of ROCO:6677 is NT$74.46 and 52 week low is NT$17.94.
When is next earnings date of Anxo Pharmaceutical Co Ltd(ROCO:6677)?
The next earnings date of Anxo Pharmaceutical Co Ltd(ROCO:6677) is .
Does Anxo Pharmaceutical Co Ltd(ROCO:6677) pay dividends? If so, how much?
Anxo Pharmaceutical Co Ltd(ROCO:6677) does not pay dividend.

Press Release

Subject Date
No Press Release